Related Experiment Video
Updated: Aug 11, 2026

Generation and Identification of GM-CSF Derived Alveolar-like Macrophages and Dendritic Cells From Mouse Bone Marrow
Published on: June 25, 2016
Langerhans cells do not express alternative macrophage activation-associated CC chemokine (AMAC)-1
1Klinik und Poliklinik für Dermatologie, Universitätsklinikum Benjamin Franklin, Freie Universität Berlin, Germany.
Insights
We identified alternative macrophage activation-associated CC chemokine-1 (AMAC-1), a novel chemokine. AMAC-1 is linked to Th2 cytokines and immune tolerance, showing distinct expression in macrophages and dendritic cells.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- CC chemokines play crucial roles in immune regulation.
- Macrophage inflammatory protein (MIP)-1alpha is a well-characterized CC chemokine.
- Alternative macrophage activation is associated with immune suppression.
Purpose of the Study:
- To clone and characterize a novel human CC chemokine, alternative macrophage activation-associated CC chemokine (AMAC)-1.
- To investigate the expression pattern of AMAC-1 in different immune cells, particularly macrophages and dendritic cells.
- To explore the potential role of AMAC-1 in T-helper cell responses and immune tolerance.
Main Methods:
- Gene cloning of AMAC-1.
- In vitro cell culture of macrophages and monocyte-derived dendritic cells.
- Cytokine stimulation (IL-4, IL-13, IL-10, GM-CSF).
- Analysis of AMAC-1 mRNA expression using techniques like RT-PCR (implied).
- Comparison of AMAC-1 expression in vitro and in vivo (Langerhans cells).
Main Results:
- AMAC-1 was cloned and found to be highly homologous to MIP-1alpha.
- AMAC-1 expression in macrophages was induced by Th2-associated cytokines (IL-4, IL-13, IL-10) in vitro.
- AMAC-1 was expressed by Th1-suppressive alveolar macrophages in vivo.
- AMAC-1 was expressed by IL-4-treated, GM-CSF-induced monocyte-derived dendritic cells in vitro.
- Epidermal Langerhans cells (a type of dendritic cell) did not express AMAC-1 mRNA in vivo.
Conclusions:
- AMAC-1 is a novel CC chemokine with a Th2-associated expression pattern.
- Its expression in alternatively activated suppressor macrophages suggests a role in inhibiting Th1 reactions.
- The absence of AMAC-1 in epidermal Langerhans cells points towards its involvement in immune tolerance induction.
Abstract:
We have cloned a novel human CC chemokine, alternative macrophage activation-associated CC chemokine (AMAC)-1 that is highly homologous to macrophage inflammatory protein (MIP)-1alpha. In contrast to MIP-1alpha, AMAC-1 is induced in macrophages by Th2-associated cytokines IL4, IL13, and IL10 in vitro; in addition, AMAC-1 is expressed by Th1-suppressive alveolar macrophages in vivo. Surprisingly, however, AMAC-1 is also expressed by GM-CSF-induced, in vitro monocyte-derived dendritic cells when treated by IL4. Here, we present a detailed analysis of AMAC-1 expression in monocyte-derived dendritic cells in vitro and show that the prime dendritic cells in vivo, i.e. epidermal Langerhans cells, do not express AMAC-1 mRNA. In conclusion, AMAC-1 is a novel CC chemokine whose Th2-associated expression pattern in alternatively activated suppressor macrophages in vivo and in vitro and its absence from epidermal Langerhans cells in vivo suggest that it may be involved in inhibition of Th1 reactions and in tolerance induction.

